Insite Vision Inc. (INSV) News Nov 14, 2014, 8:10

Insite Vision Inc. (INSV) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on INSV
InSite Vision 10-K includes 'going concern' notice 4:10 p.m. April 2, 2004 - Tom Bemis
InSite Vision closes ISV-403 sale to Bausch & Lomb 3:35 p.m. Dec. 30, 2003 - August Cole
InSite Vision closes ISV-403 sale to Bausch & Lomb 3:35 p.m. Dec. 30, 2003 - August Cole
InSite Vision to sell eye drug to Bausch & Lomb 3:55 p.m. Dec. 19, 2003 - August Cole
InSite Vision says study supports OcuGene genetic test 5:15 a.m. June 11, 2003 - Mike Maynard
InSite Vision inks term sheet to raise $1.5M 6:02 a.m. May 23, 2003 - Michael Baron
InSite Vision inks term sheet for $1.5m interim funds 5:16 a.m. May 23, 2003 - Mike Maynard
InSite Vision Q4 loss 9 cents vs yr-ago loss 11 cents 6:05 a.m. March 27, 2003 - Mike Maynard
InSite Vision receives U.S. patent allowances 6:10 a.m. Feb. 28, 2003 - Tomi Kilgore
'Free lunch': A list of stocks for short-term trading 10:57 a.m. Dec. 27, 2002 - Deborah Adamson
Advertisement
Other News on INSV
10-Q: INSITE VISION INC 4:35 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Nanosphere (NSPH) Soars: Stock Adds 26.6% in Session - Tale of the Tape 7:51 a.m. Oct. 13, 2014 - Zacks.com
Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape 7:44 a.m. Oct. 7, 2014 - Zacks.com
Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape 7:44 a.m. Oct. 6, 2014 - Zacks.com
Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% - Tale of the Tape 7:42 a.m. Oct. 6, 2014 - Zacks.com
Immunomedics (IMMU) Jumps: Stock Adds 9.1% is Session - Tale of the Tape 8:39 a.m. Sept. 30, 2014 - Zacks.com
Clovis Oncology (CLVS) Soars: Stock Adds 13.2% is Session - Tale of the Tape 7:51 a.m. Sept. 30, 2014 - Zacks.com
Merrimack Pharmaceuticals (MACK) Soars: Stock Adds 7.4% is Session - Tale of the Tape 8:39 a.m. Sept. 26, 2014 - Zacks.com
10-Q: INSITE VISION INC 4:23 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
InSite Vision's (INSV) CEO Tim Ruane on Q2 2014 Results - Earnings Call Transcript 7:52 p.m. Aug. 13, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 8:35 a.m. July 7, 2014 - Seeking Alpha
10-Q: INSITE VISION INC 3:38 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
InSite Vision's (INSV) CEO Tim Ruane on Q1 2014 Results - Earnings Call Transcript 6:05 p.m. May 14, 2014 - Seeking Alpha
10-K: INSITE VISION INC 3:47 p.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
InSite Vision's CEO Discusses Q4 2013 Results - Earnings Call Transcript 5:57 p.m. March 27, 2014 - Seeking Alpha
Edwards Lifesciences Lifted to Hold - Analyst Blog 6:26 p.m. Dec. 31, 2013 - Zacks.com
Genomic Health Remains Neutral - Analyst Blog 2:55 p.m. Dec. 27, 2013 - Zacks.com
Myriad Maintained at Neutral - Analyst Blog 5:45 p.m. Dec. 23, 2013 - Zacks.com
Affymetrix Reaches New 52-Week High - Analyst Blog 3:00 p.m. Dec. 23, 2013 - Zacks.com
Surging Rank, Surging Stock: Why InSite Vision (INSV) is a Winner? - Tale of the Tape 8:30 a.m. Dec. 18, 2013 - Zacks.com
Loading more headlines...
Press Releases on INSV
InSite Vision Reports Third Quarter 2014 Financial Results 4:07 p.m. Nov. 5, 2014 - BusinessWire - BZX
InSite Vision to Report Third Quarter 2014 Financial Results on November 5, 2014 7:30 a.m. Oct. 29, 2014 - BusinessWire - BZX
InSite Vision Reports Second Quarter 2014 Financial Results 3:05 p.m. Aug. 13, 2014 - BusinessWire - BZX
InSite Vision to Report Second Quarter 2014 Financial Results on August 13, 2014 7:31 a.m. Aug. 5, 2014 - BusinessWire - BZX
InSite Vision Announces the Issuance of Broad U.S. Patent Covering Bromfenac Formulations in DuraSite® 7:31 a.m. July 16, 2014 - BusinessWire - BZX
InSite Vision to Webcast Annual Meeting of Stockholders on July 16, 2014 3:44 p.m. July 15, 2014 - BusinessWire - BZX
InSite Vision Plans to Submit New Drug Application to FDA for DexaSite™ for the Treatment of Blepharitis in Adults 7:30 a.m. July 8, 2014 - BusinessWire - BZX
InSite Vision Announces Agreement With Noteholders to Extinguish Debt in Exchange for One-Time Payment 7:31 a.m. June 12, 2014 - BusinessWire - BZX
InSite Vision and Senju Pharmaceutical Announce Collaboration to Develop and Commercialize Azithromycin Ophthalmic Solution Using DuraSite® in Japan 7:31 a.m. June 10, 2014 - BusinessWire - BZX
InSite Vision Receives Notice of Allowance from USPTO Covering Bromfenac Formulations in DuraSite® 7:31 a.m. June 4, 2014 - BusinessWire - BZX
InSite Vision Announces Positive Meeting With Swedish Medical Products Agency Regarding Filing for Marketing Approval of BromSite™ 7:31 a.m. May 29, 2014 - BusinessWire - BZX
InSite Vision Reports First Quarter 2014 Financial Results 3:03 p.m. May 14, 2014 - BusinessWire - BZX
InSite Vision Announces Date for Annual Stockholder Meeting 3:11 p.m. May 8, 2014 - BusinessWire - BZX
InSite Vision to Report First Quarter 2014 Financial Results on May 14, 2014 3:31 p.m. May 7, 2014 - BusinessWire - BZX
InSite Vision Reports Fourth Quarter and Full-Year 2013 Financial Results 12:00 p.m. March 27, 2014 - BusinessWire - BZX
InSite Vision to Report Fourth Quarter and Year-End 2013 Financial Results on March 27, 2014 7:31 a.m. March 21, 2014 - BusinessWire - BZX
InSite Vision Announces Achievement of the $1 Million Milestone From the Sale of Besivance® Royalty 8:31 a.m. Feb. 4, 2014 - BusinessWire - BZX
InSite Vision Announces Positive Confirmatory Phase 3 Results for BromSite(TM) for the Reduction of Inflammation and Pain after Cataract Surgery 8:30 a.m. Dec. 18, 2013 - BusinessWire
InSite Vision to Host Research and Development Conference Call and Webcast on January 9, 2014 8:30 a.m. Dec. 18, 2013 - BusinessWire
InSite Vision Reports Third Quarter 2013 Financial Results 4:03 p.m. Nov. 12, 2013 - BusinessWire
Loading more headlines...